Medicare Enrolled
Dr. Robert Krasowski, M.D.
Cardiovascular Disease · High Point, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Krasowski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Krasowski?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Krasowski
Dr. Robert Krasowski is a cardiovascular disease specialist in High Point, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Krasowski performed 1,611 Medicare services across 1,120 unique beneficiaries.
Between the years covered by Open Payments, Dr. Krasowski received a total of $8,351 from 41 pharmaceutical and/or device companies across 472 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Krasowski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 47% volume in NC
$8,351 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,611
Medicare services
Top 47% in NC for cardiovascular disease
1,120
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~81 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
547 | $75 | $261 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
216 | $9 | $78 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
110 | $95 | $742 |
| Heart muscle strain imaging | 94 | $19 | $175 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
78 | $8 | $40 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
68 | $45 | $130 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
64 | $6 | $29 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
61 | $60 | $180 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
52 | $4 | $16 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
50 | $106 | $395 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
42 | $86 | $245 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
34 | $16 | $89 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
32 | $8 | $50 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
31 | $220 | $1,650 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
22 | $110 | $595 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
21 | $96 | $335 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
20 | $54 | $175 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
19 | $11 | $45 |
| CT scan of heart blood vessels and grafts with contrast A CT scan that uses contrast dye to create detailed images of the heart's blood vessels and any surgical grafts. |
13 | $87 | $418 |
| 3D radiographic procedure A radiographic imaging technique that creates three-dimensional representations of internal structures. |
13 | $7 | $39 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
13 | $43 | $310 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
11 | $132 | $495 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.8% high complexity
18.7% medium
74.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,351
Total received (2018-2024)
Avg $1,193/year across 7 years
Top 27% in NC for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
472
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,351 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,265
2023
$1,933
2022
$1,507
2021
$924
2020
$295
2019
$1,809
2018
$619
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
iRhythm Technologies, Inc.
$195
Janssen Pharmaceuticals, Inc
$178
PFIZER INC.
$112
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$109
Novo Nordisk Inc
$97
Boehringer Ingelheim Pharmaceuticals, Inc.
$67
Novartis Pharmaceuticals Corporation
$62
Lexicon Pharmaceuticals, Inc.
$57
SCPHARMACEUTICALS INC.
$56
E.R. Squibb & Sons, L.L.C.
$54
Merck Sharp & Dohme LLC
$38
Esperion Therapeutics, Inc.
$38
Amgen Inc.
$34
AstraZeneca Pharmaceuticals LP
$28
CVRx, Inc.
$28
Abbott Laboratories
$27
Kestra Medical Technology Services, Inc.
$25
HEARTFLOW, INC.
$17
SANOFI-AVENTIS U.S. LLC
$16
Kiniksa Pharmaceuticals International, plc
$15
Bayer Healthcare Pharmaceuticals Inc.
$14
Top 3 companies account for 38.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$980
Janssen Pharmaceuticals, Inc
$944
Amgen Inc.
$703
PFIZER INC.
$584
SANOFI-AVENTIS U.S. LLC
$571
E.R. Squibb & Sons, L.L.C.
$419
AstraZeneca Pharmaceuticals LP
$398
iRhythm Technologies, Inc.
$391
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$361
Merck Sharp & Dohme LLC
$351
Boehringer Ingelheim Pharmaceuticals, Inc.
$227
CVRx, Inc.
$211
Esperion Therapeutics, Inc.
$201
Merck Sharp & Dohme Corporation
$177
Amarin Pharma Inc.
$168
Bayer Healthcare Pharmaceuticals Inc.
$164
HeartFlow, Inc.
$161
Abbott Laboratories
$157
Bayer HealthCare Pharmaceuticals Inc.
$156
Novo Nordisk Inc
$133
Lundbeck LLC
$91
Actelion Pharmaceuticals US, Inc.
$90
Medtronic, Inc.
$71
Regeneron Healthcare Solutions, Inc.
$67
Boston Scientific Corporation
$65
Baxter Healthcare
$62
Lexicon Pharmaceuticals, Inc.
$57
SCPHARMACEUTICALS INC.
$56
BOSTON SCIENTIFIC CORPORATION
$47
Gilead Sciences, Inc.
$47
Impulse Dynamics (USA) Inc.
$30
Philips Electronics North America Corporation
$28
Kestra Medical Technology Services, Inc.
$25
Kowa Pharmaceuticals America, Inc.
$24
PORTOLA PHARMACEUTICALS, INC.
$23
Covidien LP
$21
Shield Therapeutics Inc
$21
Vifor Pharma, Inc.
$20
HEARTFLOW, INC.
$17
Bardy Diagnostics, Inc.
$15
Kiniksa Pharmaceuticals International, plc
$15
Top 3 companies account for 31.5% of all-time payments
Associated products mentioned in payments ›
(5091) Amb Mon & Diag Und · ACCRUFER · ANDEXXA · Arcalyst · Assure WCD · Assurity Pacemaker · BRILINTA · BYDUREON · Barostim Neo System · CHANTIX · CardioMEMS HF System · Carnation Ambulatory Monitor · Corlanor · DISEASE STATE · ELIQUIS · ENTRESTO · Endo GIA · FARXIGA · FFRct · FUROSCIX · Hillrom - Cardiac Ambulatory Monitor · INVOKANA · Inpefa · JARDIANCE · Kerendia · LEQVIO · LOKELMA · LifeVest · Livalo · MICRA · MITRACLIP · MULTAQ · Mitra Clip system · MitraClip System · NEXLETOL · NORTHERA · OPSUMIT · OPTIMIZER · Ozempic · PRADAXA · PRALUENT · Ranexa · Repatha · Reveal LINQ · Rybelsus · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · Veltassa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · ZIO AT Patch · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
85
Per 100K population
15.7
County median income
$66,027
Nearest hospital
NOVANT HEALTH THOMASVILLE MEDICAL CENTER
7.8 mi
7.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Krasowski is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Krasowski experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Krasowski performed 547 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Krasowski receive payments from pharmaceutical companies?
Yes. Dr. Krasowski received a total of $8,351 from 41 companies across 472 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Krasowski's costs compare to other cardiologists in High Point?
Dr. Krasowski's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Krasowski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in High Point
Browse cardiologists in High Point ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NC
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NC
Which NC cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology